Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
02/2003
02/11/2003US6518289 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
02/11/2003US6518260 (α-aminophosphino) peptide derivatives, method for making same and therapeutic applications thereof
02/11/2003US6518258 6-sulphamoyl -3-quinolyphosphonic acid compounds
02/11/2003US6518214 Synthesis of functionalized lithium initiator
02/11/2003CA2147375C Phosphonic diester derivatives
02/11/2003CA2092284C Conditioning shampoo composition and method of preparing and using the same
02/10/2003WO2002014336A1 Ruthenium complexes containing carboids
02/10/2003CA2419368A1 Ruthenium complexes containing carboids
02/09/2003CA2397150A1 Complex and method for producing epoxides by using the complex
02/07/2003CA2354743A1 Mitochondrially targeted antioxidants
02/06/2003WO2003010174A1 Diazaphosphacycles
02/06/2003WO2003010173A1 Stabilized derivatives of ascorbic acid -3-phosphate
02/06/2003WO2003010172A1 Process for producing highly pure riboflavin-5’-phosphate sodium
02/06/2003WO2003009874A1 Macrocyclic metal complexes and use thereof for production of conjugates with biomolecules
02/06/2003WO2003009855A2 Organo-phosphorous compounds for activating gamma/delta t cells
02/06/2003WO2003009807A2 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods
02/06/2003WO2002083988A3 Micro-engineered reactors
02/06/2003US20030028054 Synthesis of coenzyme q10 ubiquinone
02/06/2003US20030028042 Il8-receptor antagonists
02/06/2003US20030027800 LPA receptor agonists and antagonists and methods of use
02/06/2003US20030027742 Pumpable, surfactants
02/06/2003US20030027357 ECL labels having improved non-specific binding properties, methods of using and kits containing the same
02/06/2003US20030027302 Ligand for use in radioimmunotherapy
02/06/2003CA2453106A1 Macrocyclic metal complexes and use thereof for production of conjugates with biomolecules
02/06/2003CA2452159A1 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods
02/05/2003EP1280812A1 Cyclipostins, a method for their production and the use of the same
02/05/2003EP1280811A1 Hydroformylation method, bridged compounds of phosphorus, arsenic and antimony and catalyst comprising a complex of said bridged compounds
02/05/2003EP1280805A1 Novel imidazotriazinones and the use thereof
02/05/2003EP1280784A2 Biologically active 4h-benzo 1,4]oxazin-3-ones
02/05/2003EP1150989B1 Metal complexes as catalyst component for olefin polymerisation
02/05/2003EP1019062B1 Osteoblast-specific mitogens and drugs containing such compounds
02/05/2003EP0983280B1 Process to prepare bridged phosphole-cyclopentadienyl compounds
02/05/2003EP0819760B1 Process for producing phosphatidylserines having polybasic unsaturated fatty acid as side chain
02/05/2003CN1395578A Byrido [2,3-d] pyrimidine-2, 7-diamine kinase inhibitors
02/05/2003CN1395485A Water soluble prodrugs of azole compounds
02/05/2003CN1100882C Process for interesterification of phospholipids
02/05/2003CN1100799C Method for proudcing cycloolefin or (co) polymers for industrial applications
02/05/2003CN1100783C Method for producing vinyl phosphonic acid compounds
02/05/2003CN1100771C Phosphononooxymethyl ethers for taxame derivatives
02/05/2003CN1100752C Manufacturing process for 6-aminocapronitrile
02/04/2003WO2002014333A1 Phosphonocephem compound
02/04/2003US6515183 Chiral diphenyldiphosphines and d-8 metal complexes thereof
02/04/2003US6515168 Process for preparing N-phosphonomethyl iminodiacetic acid
02/04/2003US6515161 Hydroformylation process utilizing multidentate phosphite ligands
02/04/2003US6515156 Stereoselective, efficient catalyst for synthesis of enantiomerically pure compounds; comprising compex of transition metal and aminophosphine ligand
02/04/2003US6515124 Dehydroamino acids
02/04/2003US6515084 Used to catalyze ring opening polymerization, depolymerization of unsaturated polymers, systhesis of telechelic polymers, synthesizing olefins and cross metathesis of 2 acyclic olefins
02/04/2003US6515051 Benzotriazole UV absorbers having enhanced durability
02/04/2003US6514987 Useful for inactivating pathogens in a material, such as a blood product, and then degrades to breakdown products
02/04/2003US6514953 Calcium (3S) tetrahydro-3-furanyl(1S,2R)-3-[[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-(phosphonooxy)propylcarbamate
02/04/2003US6514717 Kit for conducting an assay to detect a substance using enzymatically-induced decomposition of dioxetanes
02/04/2003US6514684 Bisphenol-phosphorous compound complex and thermally processed image recording material utilizing the same
02/04/2003US6514434 Electro-optic chromophore bridge compounds and donor-bridge compounds for polymeric thin film waveguides
02/04/2003CA2357805C Oligomerization catalyst precursor
02/04/2003CA2108268C Improved process for recovery of purified terephthalic acid
01/2003
01/30/2003WO2003008546A2 Biogenic fpa: enzymatic production of formylphosphonic acid by the oxidation of hydroxymethylphosphonic acid
01/30/2003WO2003008516A1 Red fluorescent material and composition containing the same
01/30/2003WO2003008427A1 Gold compounds simultaneously coordinated by mono- and bidentate phosphines having antitumoral activity
01/30/2003WO2003008426A1 Flame retardant for polymeric materials
01/30/2003WO2003008425A1 Novel bisphosphonate derivatives, their preparation methods and uses
01/30/2003WO2003008394A1 Novel chelating agents and conjugates thereof, their synthesis and use as diagnostic and therapeutic agents
01/30/2003WO2003008390A1 Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy
01/30/2003WO2003002580A8 6-`2-(phosphonomethoxy)alkoxy pyrimidine derivatives having antiviral activity
01/30/2003WO2002064250A3 Process for the carbonylation of ethylenically unsaturated compounds, bidentate diphosphine composition used in this process and processes for preparation of this bidentate diphosphine composition
01/30/2003US20030023123 Reduced production of unwanted byproducts; purity, efficiency
01/30/2003US20030023110 Reacting an acyclic, aliphatic, monoethylenically unsaturated compound with a source of HCN in the presence of a catalyst precursor composition comprising a Lewis acid, a zero- valent nickel, and a multidentate phosphite ligand for hydrocyanation
01/30/2003US20030023107 Reacting alkyl (meth)acrylate with dialkylphosphonated alcohol in presence of a catalyst comprising zirconium acetylacetonate to form dialkylphosphono)alkyl (meth)acrylate
01/30/2003US20030023089 Compounds, compositions and methods for generating chemiluminescence with phosphatase enzymes
01/30/2003US20030023050 Actinium-225 complexes and conjugates for targeted radiotherapy
01/30/2003US20030022914 Nitric oxide synthase inhibitors
01/30/2003US20030022869 For blocking prenylation transferase enzymes; anticancer agents; stability
01/30/2003US20030022865 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
01/30/2003US20030022172 Polyamide nucleic acid derivatives and agents and processes for preparing them
01/30/2003CA2459844A1 Flame retardant for polymeric materials
01/30/2003CA2452243A1 Red fluorescent material and composition containing the same
01/30/2003CA2451881A1 Novel bisphosphonate derivatives, their preparation methods and uses
01/29/2003EP1279674A2 Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as TACE inhibitors
01/29/2003EP1279660A1 Process for producing an optically active amide from an alpha, beta-unsaturated amide derivative in the presence of a transition metal complex containing a phosphine-phosphorane compound and a transition metal
01/29/2003EP1278784A2 Catalysts containing n-pyrrolyl substituted nitrogen donors
01/29/2003EP1278759A1 Bis-(n,n'-bis-(2-haloethyl)amino) phosphoramidates as antitumor agents
01/29/2003EP1278758A1 Combretastatin a-1 phosphate and combretastatin b-1 phosphate prodrugs
01/29/2003EP1278737A2 Process and intermediates for making substituted aspartic acid acetals
01/29/2003EP1278549A2 Cyclodextrin containing glycopeptide antibiotic compositions
01/29/2003EP1117669B1 Antiviral purine derivatives
01/29/2003EP1105387B1 Prodrugs of proton pump inhibitors
01/29/2003EP0983255B1 Substituted 2-benzoyl-cyclohexane-1,3-diones
01/29/2003EP0754175B1 Alkoxy-alkyl-substituted 1-h-3-aryl-pyrrolidine-2,4-diones used as herbicides and pesticides
01/29/2003CN1100059C Sulfonic acid-containing organic phosphine carboxylic acid compound, its preparing process and application
01/29/2003CN1099912C Process for preparation by hydrogenation of catalysts based on transition metal and phosphine
01/28/2003US6512133 Process for the production of phosphoric acid esters or phosphoric acid ester mixtures of polyhydric alcohols and use thereof
01/28/2003US6511990 Class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof
01/28/2003US6511965 Ether type lipid A 1-carboxylic acid analogs
01/28/2003US6511936 Catalyst compounds with β-diminate anionic ligands and processes for polymerizing olefins
01/28/2003US6511706 MOCVD of SBT using tetrahydrofuran-based solvent system for precursor delivery
01/28/2003US6511677 Polymerizable fatty acids, phospholipids and polymerized liposomes therefrom
01/23/2003WO2003006547A1 Antibacterial composition for medical tool
01/23/2003WO2003006472A1 Method for manufacturing dicyclic phosphorus melamine compounds having superior fire retardancy and fire retardant material using thereof
01/23/2003WO2003006454A2 Heterocyclic carboxamides and their use as fungicides
01/23/2003WO2003006440A2 Amide-containing compound having improved solubility and method of improving the solubility of an amide-containing compound
01/23/2003WO2003005973A1 Dental self-etching primer